These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
173 related items for PubMed ID: 6311539
1. Nucleic acid sequence of the region of the genome encoding capsid protein VP1 of neurovirulent and attenuated type 3 polioviruses. Stanway G, Cann AJ, Hauptmann R, Mountford RC, Clarke LD, Reeve P, Minor PD, Schild GC, Almond JW. Eur J Biochem; 1983 Oct 03; 135(3):529-33. PubMed ID: 6311539 [Abstract] [Full Text] [Related]
2. Genetic basis of the neurovirulence of type 1 polioviruses isolated from vaccine-associated paralytic patients. Li J, Zhang LB, Yoneyama T, Yoshida H, Shimizu H, Yoshii K, Hara M, Nomura T, Yoshikura H, Miyamura T, Hagiwara A. Arch Virol; 1996 Oct 03; 141(6):1047-54. PubMed ID: 8712922 [Abstract] [Full Text] [Related]
3. A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain. Kohara M, Abe S, Komatsu T, Tago K, Arita M, Nomoto A. J Virol; 1988 Aug 03; 62(8):2828-35. PubMed ID: 2839704 [Abstract] [Full Text] [Related]
4. Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine. Bouchard MJ, Lam DH, Racaniello VR. J Virol; 1995 Aug 03; 69(8):4972-8. PubMed ID: 7609067 [Abstract] [Full Text] [Related]
6. Identification of a consistent pattern of mutations in neurovirulent variants derived from the sabin vaccine strain of poliovirus type 2. Equestre M, Genovese D, Cavalieri F, Fiore L, Santoro R, Perez Bercoff R. J Virol; 1991 May 03; 65(5):2707-10. PubMed ID: 1850043 [Abstract] [Full Text] [Related]
10. Nucleotide sequence of a neurovirulent variant of the type 2 oral poliovirus vaccine. Pollard SR, Dunn G, Cammack N, Minor PD, Almond JW. J Virol; 1989 Nov 03; 63(11):4949-51. PubMed ID: 2552175 [Abstract] [Full Text] [Related]
11. Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates. Macadam AJ, Pollard SR, Ferguson G, Skuce R, Wood D, Almond JW, Minor PD. Virology; 1993 Jan 03; 192(1):18-26. PubMed ID: 8390752 [Abstract] [Full Text] [Related]
12. In vitro phenotypic markers of a poliovirus recombinant constructed from infectious cDNA clones of the neurovirulent Mahoney strain and the attenuated Sabin 1 strain. Kohara M, Omata T, Kameda A, Semler BL, Itoh H, Wimmer E, Nomoto A. J Virol; 1985 Mar 03; 53(3):786-92. PubMed ID: 2983090 [Abstract] [Full Text] [Related]
14. Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype. Kawamura N, Kohara M, Abe S, Komatsu T, Tago K, Arita M, Nomoto A. J Virol; 1989 Mar 03; 63(3):1302-9. PubMed ID: 2536835 [Abstract] [Full Text] [Related]
19. Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa. Pavlov DN, Van Zyl WB, Van Heerden J, Kruger M, Blignaut L, Grabow WO, Ehlers MM. J Appl Microbiol; 2006 Dec 03; 101(6):1367-79. PubMed ID: 17105568 [Abstract] [Full Text] [Related]